Automation · Vendor Strategy · AI
Technology rollouts are increasingly reversed after a measured trial
What is changing
More organisations run a short measured trial of a new tool, watch a real outcome metric, and pull the rollout if the metric gets worse — instead of adopting on the vendor's case and reviewing later. It shows up most where an AI feature touches a customer-facing number.
Why it matters
Vendor land-and-expand assumes that once a tool is in it stays; that assumption is weakening.
Opportunity
Ship with the outcome metric instrumented from day one, so the value is visible before the trial that decides whether the tool survives.
Early evidence
What Quettor is checking next
Which reversed rollouts stay reversed, and which come back once teams adapt to the tool?